| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $2.75B | -10.8% |
| Cost of Revenue | $1.89B | -7.9% |
| Gross Profit | $859.0M | -16.7% |
| R&D Expense | $49.6M | +12.3% |
| SG&A Expense | $540.1M | +7.1% |
| Operating Income | $50.5M | -53.2% |
| Income Tax | -$9.0M | -114.9% |
| Net Income | -$5.5M | +43.4% |
| EPS (Basic) | -$0.10 | +41.2% |
| EPS (Diluted) | -$0.10 | +41.2% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $60.3M | -30.1% |
| Accounts Receivable | $355.9M | +4.9% |
| Inventory | $610.0M | -14.1% |
| Current Assets | $1.08B | -10.1% |
| Total Assets | $2.40B | -14.2% |
| Current Liabilities | $385.3M | -15.1% |
| Long-term Debt | $717.2M | -31.7% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $400.9M | -17.5% |
| Capital Expenditures | $30.5M | -21.3% |
| Investing Cash Flow | -$46.7M | +94.1% |
| Financing Cash Flow | -$380.4M | -203.6% |
| Free Cash Flow | $370.4M | -17.2% |
| Total Liabilities |
| $1.28B |
| -23.5% |
| Stockholders' Equity | $1.13B | -0.5% |